Dapagliflozin vs Imatinib

Dapagliflozin vs Imatinib: Overview

This comparison examines the pharmacological differences between Dapagliflozin and Imatinib.

Mechanism of Action

Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Pharmacokinetics

Half-life: Dapagliflozin — 12.9 hours; Imatinib — 18 hours.

Chemical Properties

Molecular Formula: Dapagliflozin — C21H25ClO6; Imatinib — C29H31N7O.

Molecular Weight: Dapagliflozin — 408.8730 g/mol; Imatinib — 493.6030 g/mol.

Type: Dapagliflozin — Small molecule; Imatinib — Small molecule.